ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
-0,12%
Bitcoin
69.304,02
-0,04%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Immunotech Laborator (CE) (IMMB)

  7. Immunotech Laborator (CE) (IMMB) News

IMMB

Immunotech Laborator (CE) (IMMB)

Immunotech Laborator (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:IMMB
DatumZeitQuelleÜberschriftSymbolFirma
10/01/201415h00Access WireImmunotech Laboratories Inc. Corporate UpdateUSOTC:IMMBImmunotech Laborator (CE)
01/10/201319h10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMMBImmunotech Laborator (CE)
25/09/201306h00OTC MarketsTier ChangeUSOTC:IMMBImmunotech Laborator (CE)
19/06/201315h05GlobeNewswire Inc.Immunotech Laboratories, Inc. Announces the Results From Gap Analysis ReportUSOTC:IMMBImmunotech Laborator (CE)
13/06/201318h36Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:IMMBImmunotech Laborator (CE)
13/06/201312h01Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:IMMBImmunotech Laborator (CE)
30/05/201315h00GlobeNewswire Inc.Immunotech Laboratories ITV-1 Manufacturing AnnouncementUSOTC:IMMBImmunotech Laborator (CE)
28/05/201315h00GlobeNewswire Inc.Immunotech Laboratories Signs Funding Agreement With Curing Capital, Inc.USOTC:IMMBImmunotech Laborator (CE)
09/05/201315h00GlobeNewswire Inc.Immunotech Laboratories Corporate Shareholder Update SummaryUSOTC:IMMBImmunotech Laborator (CE)
29/04/201317h11GlobeNewswire Inc.Immunotech Laboratories, Inc. Provides Funding UpdateUSOTC:IMMBImmunotech Laborator (CE)
26/04/201315h00MarketwiredImmunotech Laboratories Begins Regulatory Process With US Food & Drug AdministrationUSOTC:IMMBImmunotech Laborator (CE)
15/04/201315h25MarketwiredImmunotech Laboraties Appoints New VP of Business DevelopmentUSOTC:IMMBImmunotech Laborator (CE)
08/04/201315h53MarketwiredImmunotech Laboraties Retains The Lebrecht Group to Upgrade the Company to Fully Reporting StatusUSOTC:IMMBImmunotech Laborator (CE)
05/04/201311h00MarketwiredMoneyTV with Donald Baillargeon, 4/5USOTC:IMMBImmunotech Laborator (CE)
28/03/201310h00MarketwiredMoneyTV with Donald Baillargeon, 3/28USOTC:IMMBImmunotech Laborator (CE)
25/03/201319h07Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)USOTC:IMMBImmunotech Laborator (CE)
25/03/201319h06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMMBImmunotech Laborator (CE)
18/03/201314h00MarketwiredImmunotech Laboraties in Discussions for Pre-"IND" Testing of Aids-HIV "IPF" Treatment in the USAUSOTC:IMMBImmunotech Laborator (CE)
12/03/201315h45MarketwiredImmunotech Founder & Chief Scientific Officer Harry Zhabilov Comments on Recent HIV Baby Cure MedicineUSOTC:IMMBImmunotech Laborator (CE)
07/03/201315h12MarketwiredImmunotech Announces Canadian Special Access Program Could Allow Legal Treatment of Company's Patented (IPF-ITV-1) AIDS-HIV T...USOTC:IMMBImmunotech Laborator (CE)
01/03/201315h15MarketwiredImmunotech Relocates to New Research & Development Laboratory FacilityUSOTC:IMMBImmunotech Laborator (CE)
04/02/201322h56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMMBImmunotech Laborator (CE)
04/02/201314h40Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMMBImmunotech Laborator (CE)
28/11/201219h31MarketwiredImmunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage PatientsUSOTC:IMMBImmunotech Laborator (CE)
11/10/201212h02Edgar (US Regulatory)Current report filing (8-K)USOTC:IMMBImmunotech Laborator (CE)
19/09/201223h18Edgar (US Regulatory)Current report filing (8-K)USOTC:IMMBImmunotech Laborator (CE)
05/09/201221h31MarketwiredUpdate to Immunotech Laboratories, Inc. ShareholdersUSOTC:IMMBImmunotech Laborator (CE)
13/06/201219h03Edgar (US Regulatory)Current report filing (8-K)USOTC:IMMBImmunotech Laborator (CE)
13/01/201112h01Edgar (US Regulatory)Current report filing (8-K)USOTC:IMMBImmunotech Laborator (CE)
05/01/201114h49Edgar (US Regulatory)Annual Report (10-K)USOTC:IMMBImmunotech Laborator (CE)
 Showing the most relevant articles for your search:USOTC:IMMB

Kürzlich von Ihnen besucht

TG
CBK
Commerzbank
CCOM
US500
US 500
FX
EURUSD
Euro vs US Dollar
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
TG
432
Arbor Metals
TG
TUI1
Tui
USOTC
BASFY
BASF (QX)
AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
PM
XAUUSD
Gold vs US Dollar
TG
BAYN
Bayer
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten